Meanwhile, ALYREF deficiency exerted an inhibitory effect on HCC tumors in vivo; ALYREF knockdown significantly inhibited the proliferation of HCC cells and increased their apoptosis rate (Xue et al., 2023; Nulali et al., 2024). The gene discussed is ALYREF; the disease is hepatocellular carcinoma.